{
  "as_of": "2026-10-23",
  "state": "AL",
  "name": "Alabama",
  "status": "not-covered",
  "statusLabel": "Not covered for obesity alone",
  "effective": "2026-10-01",
  "effectiveWhat": "criteria in effect",
  "note": "No obesity-only route. Wegovy for heart-risk reduction or MASH, Zepbound for sleep apnea, with prior authorization.",
  "source": {
    "title": "Alabama Medicaid PA Criteria Instructions, eff. 10/01/2026",
    "url": "https://medicaid.alabama.gov/documents/9.0_Resources/9.4_Forms_Library/9.4.13_Pharmacy_Services/9.4.13_PH_Prior_Authorization_Criteria_10-5-26.pdf"
  },
  "read": "2026-10-23",
  "url": "https://kymatahealth.com/telehealth/glp1-coverage-map",
  "page": "https://kymatahealth.com/telehealth/glp1-coverage-map/alabama",
  "cite": "https://kymatahealth.com/telehealth/glp1-coverage-map/alabama"
}